{"id":33387,"date":"2025-09-15T11:03:05","date_gmt":"2025-09-15T11:03:05","guid":{"rendered":"https:\/\/www.hotelsalepage.com\/feed\/cision-pr-newswire\/clinically-proven-human-milk-probiotic-lc40-supports-infant-health-and-breastfeeding-mothers\/"},"modified":"2025-09-15T11:03:05","modified_gmt":"2025-09-15T11:03:05","slug":"clinically-proven-human-milk-probiotic-lc40-supports-infant-health-and-breastfeeding-mothers-2","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=33387","title":{"rendered":"Clinically Proven Human Milk Probiotic LC40\u00ae supports Infant Health and Breastfeeding Mothers"},"content":{"rendered":"\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

SINGAPORE<\/span><\/span>, Sept. 15, 2025<\/span><\/span> \/PRNewswire\/ —\u00a0Supported by six clinical studies and two safety trials, Kerry<\/a>‘s LC40\u00ae<\/sup> is the first probiotic strain of its kind validated for both infant and maternal applications, offering a natural, science-backed approach to early life and maternal health.<\/p>\n

\n

\"Human <\/a>
Human milk probiotics bridges nature and innovation to support both infant health and maternal well-being.<\/span><\/p>\n<\/div>\n

Human Milk Probiotics<\/a>\u00a0are strains of beneficial bacteria, specifically including Lactobacillus and Bifidobacterium, naturally found in breast milk. Kerry, in collaboration with the Complutense University of Madrid<\/span>, is the first to isolate these strains, including LC40\u00ae<\/sup> and BfM26\u00ae<\/sup>, using an in-house screening method that evaluated over 40 criteria to select the most potent candidates.<\/p>\n

LC40\u00ae<\/sup> Infant supports gut and immune health in babies, especially those born via C-section or fed with formula, who may miss out on the natural microbial transfer during vaginal birth and breastfeeding. Backed by six clinical studies and two safety trials, LC40\u00ae<\/sup> has been shown to reduce gastrointestinal infections by 48% and respiratory infections by 27%, while promoting a microbiome similar to that of breastfed infants.<\/p>\n

LC40\u00ae<\/sup> Breastcare addresses one of the most common challenges in early motherhood and women’s health<\/a>: mastitis. Affecting up to 30% of breastfeeding women, mastitis can lead to pain, emotional distress, and early cessation of breastfeeding. LC40\u00ae<\/sup> has demonstrated a 51% reduction in mastitis incidence[1]<\/span><\/sup> and significantly improved emotional well-being[2]<\/sup><\/span> and women’s health, with 88% of women reporting complete symptom resolution[3]<\/span><\/sup> compared to just 29% in the antibiotic group.<\/p>\n

“Human Milk Probiotics like LC40\u00ae<\/sup> are redefining how we support health in the first 1,000 days of life,” said Dr. Monica Maria Olivares<\/span>, RD&A Director, Women & Infant Health at Kerry. “They offer a natural yet science-driven solution to some of the most pressing challenges in early life nutrition, from microbial gaps in newborns to breastfeeding complications in mothers. LC40\u00ae<\/sup> is not just a probiotic; it’s a holistic intervention for better outcomes”.<\/p>\n

LC40\u00ae<\/sup> is also gaining traction in neonatal care. When administered alongside BfM26\u00ae<\/sup> in preterm infants, the probiotic duo significantly reduced the risk of necrotising enterocolitis (NEC) and lowered mortality rates. Additionally, LC40\u00ae<\/sup> has shown long-term growth benefits, with formula-fed infants demonstrating improved length gains that persisted up to two years of age.<\/p>\n

With certifications including NDI, QPS, China FDA, Kosher, Halal, Non-GMO, and Gluten-Free, LC40\u00ae is suitable for a wide range of applications, from infant formula to maternal supplements. Its patented ExLCusive\u2122 fermentation process ensures genomic-DNA security and consistent quality.<\/p>\n

As the Asia Pacific<\/span> probiotics market surpasses USD3.6 billion<\/span> in 2024 and continues to grow at a CAGR of 6.3%, LC40\u00ae<\/sup> represents a clinically supported innovation that aligns with consumer demand for natural, microbiome-supportive solutions in maternal and infant health.<\/p>\n

\n\n\n\n\n
\n

References:<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

\u00a0[1] Hurtado et al. Breastfeed Med. 2017 May 1; 12(4): 202\u2013209
[2] Maldonado-Lobon et al. Breastfeed Med 2015. 10(9):425-32
[3] Arroyo et al Clin Infect Dis. 2010 Jun \u00a015;50(12):1551-8<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n<\/div>","protected":false},"excerpt":{"rendered":"

<\/p>\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

SINGAPORE<\/span><\/span>, Sept. 15, 2025<\/span><\/span> \/PRNewswire\/ —\u00a0Supported by six clinical studies and two safety trials, Kerry<\/a>‘s LC40\u00ae<\/sup> is the first probiotic strain of its kind validated for both infant and maternal applications, offering a natural, science-backed approach to early life and maternal health.<\/p>\n

\n

\"Human <\/a>
Human milk probiotics bridges nature and innovation to support both infant health and maternal well-being.<\/span><\/p>\n<\/div>\n

Human Milk Probiotics<\/a>\u00a0are strains of beneficial bacteria, specifically including Lactobacillus and Bifidobacterium, naturally found in breast milk. Kerry, in collaboration with the Complutense University of Madrid<\/span>, is the first to isolate these strains, including LC40\u00ae<\/sup> and BfM26\u00ae<\/sup>, using an in-house screening method that evaluated over 40 criteria to select the most potent candidates.<\/p>\n

LC40\u00ae<\/sup> Infant supports gut and immune health in babies, especially those born via C-section or fed with formula, who may miss out on the natural microbial transfer during vaginal birth and breastfeeding. Backed by six clinical studies and two safety trials, LC40\u00ae<\/sup> has been shown to reduce gastrointestinal infections by 48% and respiratory infections by 27%, while promoting a microbiome similar to that of breastfed infants.<\/p>\n

LC40\u00ae<\/sup> Breastcare addresses one of the most common challenges in early motherhood and women’s health<\/a>: mastitis. Affecting up to 30% of breastfeeding women, mastitis can lead to pain, emotional distress, and early cessation of breastfeeding. LC40\u00ae<\/sup> has demonstrated a 51% reduction in mastitis incidence[1]<\/span><\/sup> and significantly improved emotional well-being[2]<\/sup><\/span> and women’s health, with 88% of women reporting complete symptom resolution[3]<\/span><\/sup> compared to just 29% in the antibiotic group.<\/p>\n

“Human Milk Probiotics like LC40\u00ae<\/sup> are redefining how we support health in the first 1,000 days of life,” said Dr. Monica Maria Olivares<\/span>, RD&A Director, Women & Infant Health at Kerry. “They offer a natural yet science-driven solution to some of the most pressing challenges in early life nutrition, from microbial gaps in newborns to breastfeeding complications in mothers. LC40\u00ae<\/sup> is not just a probiotic; it’s a holistic intervention for better outcomes”.<\/p>\n

LC40\u00ae<\/sup> is also gaining traction in neonatal care. When administered alongside BfM26\u00ae<\/sup> in preterm infants, the probiotic duo significantly reduced the risk of necrotising enterocolitis (NEC) and lowered mortality rates. Additionally, LC40\u00ae<\/sup> has shown long-term growth benefits, with formula-fed infants demonstrating improved length gains that persisted up to two years of age.<\/p>\n

With certifications including NDI, QPS, China FDA, Kosher, Halal, Non-GMO, and Gluten-Free, LC40\u00ae is suitable for a wide range of applications, from infant formula to maternal supplements. Its patented ExLCusive\u2122 fermentation process ensures genomic-DNA security and consistent quality.<\/p>\n

As the Asia Pacific<\/span> probiotics market surpasses USD3.6 billion<\/span> in 2024 and continues to grow at a CAGR of 6.3%, LC40\u00ae<\/sup> represents a clinically supported innovation that aligns with consumer demand for natural, microbiome-supportive solutions in maternal and infant health.<\/p>\n

\n\n\n\n\n
\n

References:<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

\u00a0[1] Hurtado et al. Breastfeed Med. 2017 May 1; 12(4): 202\u2013209
[2] Maldonado-Lobon et al. Breastfeed Med 2015. 10(9):425-32
[3] Arroyo et al Clin Infect Dis. 2010 Jun \u00a015;50(12):1551-8<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

\u00a0<\/p>\n

\n<\/div>\n

<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-33387","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/33387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33387"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/33387\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}